Heligenics
LAS VEGAS, NV · Biotechnology · 10 employees
Heligenics is a life sciences company that has developed proprietary technology, which shows the impact of genetic mutations to revolutionize genetic testing and drug development for major diseases. We are the first company to develop High Content Screening for Biologic Drugs, previously the mainstay for the development of small compound drugs.
Funding history
- Seed — $2.6M — Jan 2025
- Seed — $2.2M — Aug 2022
- Seed — $1.2M — Dec 2020
Recent signals
- Jan 08, 2025: Raised $2.6M in Seed
- Aug 23, 2022: Raised $2.2M in Seed
- Dec 16, 2020: Raised $1.2M in Seed
See plans & pricing → Track Heligenics’s funding, hiring, and signals — with verified contacts — on Fundz.